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DESARROLLO DE DIABETES MELLITUS TIPO 2
TREINTA Y UN AÑOS DESPUÉS DE BILLROTH II
EN UN PACIENTE QUE SOLICITA CIRUGÍA DE
DIABETES
Resumen
Introducción: La cirugía de la diabetes en pacientes
obesos y delgados parece ser una alternativa superior al
tratamiento médico actual. El bypass gástrico es un trata-
miento alternativo al tratamiento médico actual. Sin em-
bargo, todavía hay dudas sobre si la diabetes puede rea-
parecer si hay aumento de peso o si se mantienen los
efectos en el tiempo. Otras preguntas se refieren al tipo de
cirugía para hacer la longitud del remanente gástrico o el
tamaño del reservorio para la resolución de la Diabetes
Mellitus.
Presentación del caso: Paciente masculino de 69 años
de edad, vino a nosotros con el fin de realizar el bypass
gástrico de una anastomosis a medida (BAGUA) para
tratar su diabetes mellitus tipo 2 y el síndrome metabóli-
co. Tiene antecedentes de úlcera péptica tratado con gas-
trectomía subtotal y reconstrucción tipo Billroth II hace
49 años. Actualmente él no es obeso y desarrolló diabetes
31 años después de la cirugía. 
Discusión: A nivel mundial no hay reportes de pacien-
tes con IMC normal que después de realizar un bypass
gástrico desarrollaron diabetes mellitus. Hay casos en
que los pacientes diabéticos obesos después del bypass
gástrico mejoran o remite la DMT2, pero reaparece debi-
do a la pérdida de peso insuficiente o reganancia de él. El
paciente con un bypass gástrico tipo Billroth II, no debió
desarrollar diabetes. Él tiene peso normal y no ha aumen-
tado de peso que podría estar relacionado con el desarro-
llo de diabetes.
Conclusión: Los resultados generados por la cirugía
bariátrica son alentadores, pero aún no aclaran la forma
precisa cómo la cirugía produce una rápida mejoría del
metabolismo sistémico como la diabetes, pero en nuestro
paciente, el efecto fue muy diferente debido a que el by-
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Abstract
Introduction: Diabetes surgery in obese and slim
patients seems to be a superior alternative to the current
medical treatment. Gastric bypass is an alternative treat-
ment for diabetes. Nevertheless, there are still doubts
whether diabetes can recur if you gain weight or if the
effects are maintained over time. Other questions refer to
the type of surgery to make the bypass limb length or
reservoir size for the resolution of the Diabetes Mellitus. 
Presentation of case: Male patient 69-year-old came to
us in order to perform tailored One Anastomosis Gastric
Bypass (BAGUA) to treat his type 2 diabetes mellitus and
metabolic syndrome. He has a history of peptic ulcer
treated with subtotal gastrectomy and Billroth II recons-
truction 49 years ago. He currently is not obese and deve-
loped diabetes 31 years after surgery.
Discussion: Globally there are no reports of patients
with normal BMI that after performing gastric bypass
developed diabetes mellitus. There are cases where obese
diabetic patients after gastric bypass improve or remits
the T2DM, but it relapses due to insufficient weight loss
or gain it. The patient with gastric bypass Billroth II type,
should not developed diabetes. He is normal weight and
not had weight gain that could be linked to the develop-
ment of diabetes.
Conclusions: The results generated by bariatric
surgery are encouraging, but still do not clarify the
precise way how surgery produces rapid improvement of
systemic metabolism as in diabetes, but in our patient, the
effect was quite different because the gastric bypass had
no protective effect against diabetes.
(Nutr Hosp. 2014;30:219-221)
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Abbreviations
BMI: Body Mass Index.
BAGUA: One Anastomosis Gastric Bypass. 
T2DM: Type 2 Diabetes Mellitus.
Introduction
Diabetes surgery in obese and slim patients seems to
be a superior alternative to the current medical treat-
ment1,2. There are still doubts whether diabetes can
recur if you gain weight or if the effects are maintained
over time. Other questions refer to the type of surgery
to make the bypass limb length or reservoir size for the
resolution of the Diabetes Mellitus3.
The first experiences come from Friedman et al.4,
who in 1955 reported cases of patients after subtotal
gastrectomy Billroth II type for peptic ulcer having
diabetes mellitus. Patients had ulcer healing and a
marked improvement of diabetes, as manifested by the
reduction or elimination of insulin requirements. The
same results were found with the Greenville Gastric
Bypass that nobody still practices5.
Since then it has been investigated how duodenal
exclusion can control diabetes, beginning a new alter-
native of treatment for diabetes mellitus, where several
studies have followed-up diabetic patients after gastric
bypass. Pories et al.6 studied for 14 years to 608
patients of whom 165 were diabetic, determining that
the surgery provides long-term control of diabetes.
SOS study also revealed that bariatric surgery not
only cures but also prevents the onset of diabetes7.
Nevertheless, GarcíaCaballero et al.2 has shown that
the resolution of diabetes mellitus is not only present in
obese but also in normal weight patients even with C-
peptide zero to whom eliminates the use of fast-acting
insulin and reduces to a minimum the necessity of
long-acting insulin enhancing glycemic control8.
In this context, we have experienced a case where a
man came to us asking for diabetes surgery and the
preoperative study found that the patient had been
operated 49 years before for Billroth II because of
duodenal ulcer. The patient have always had normal
BMI.
Presentation of case
Male patient 69-year-old came to us in order to
perform the tailored One Anastomosis Gastric Bypass
(BAGUA) to treat his type 2 diabetes mellitus (T2DM)
and metabolic syndrome. He has a history of peptic
ulcer treated surgically with gastrectomy and Billroth
II reconstruction 49 years ago. Then he developed
T2DM 18 years ago, who despite intensive medical
treatment based on oral hypoglycemic and insulin has
not achieved an adequate control of blood glucose. He
had also arterial hypertension and dyslipidemia.
Physical examination is weight of 66 kg, height 1.70
m, BMI 22.8 and TA 181/82.
His treatment is irbesartan 300 mg, metformin 850
mg, 20 mg omeprazole, ramipril 10 mg, aspirin 100
mg, atorvastatin 20 mg, 10 mg lercanidipine, 27 IU
insulin glulisine and 24 IU insulin glargine per day.
Laboratory levels are glucose 192 mg/dL, triglycerides
100 mg/dL, cholesterol 160 mg/dL, HDL 41 mg/dL,
LDL, 99 mg/dL, HbA1c 7.8% and C-peptide 2.14 ng/mL.
The oesophagogram shows minimum gastroe-
sofagic reflux, Billroth II gastrectomy with wide
gastroenterostomy and fast transit to the jejunum. The
duodenal afferent loop shows no fill (figs. 1 and 2).
Discussion
Globally there are no reports of patients with normal
BMI that after performing gastric bypass develop
diabetes mellitus. There are cases where obese diabetic
patients after gastric bypass improve or remits the T2DM,
but it relapses due to insufficient weight loss or gain it.
The existing series of patients worldwide usually
have remission of diabetes mellitus in obese patients6,7.
Fig. 1.—
Fig. 2.—
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However, there are few studies on normal weight
patients. They are operated with the premise that if
bariatric surgery improves diabetes in obese patients,
also can be applied to normal weight patients achieving
resolution of diabetes9. However all these studies have
limitations due to their structure, type of surgical
procedures, BMI, time following, etc.
Questions remain without response as either how
surgery helps in diabetes or which surgical procedure is
appropriate1.
Our patient with a gastric bypass Billroth II type
should not develop diabetes. He is normal weight and
not had weight gain that could be linked to the develop-
ment of diabetes. He has also a reorganization of the
gastrointestinal tract with appropriate hormonal modu-
lation, but he developed diabetes. The new data gene -
rated are encouraging, but still do not clarify the
precise way about how bariatric surgery produces rapid
improvement of systemic metabolism10, which is the
challenge for future research.
Conclusion
The results generated by bariatric surgery worldwide
are encouraging, but not clear precisely how the surgery
produces rapid improvement of systemic metabolism. It
is well known that bariatric surgery causes improvement
and/or resolution of various diseases such as diabetes,
and some authors mention that gastric bypass is protec-
tive against the onset of diabetes, but in our case, the
effect was very different because gastric bypass had no
protective effect against diabetes.
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